| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 1129-1132, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
MP Shekhar, P Nangia-Makker, SR Wolman, L Tait, GH Heppner and DW Visscher
Breast Cancer Program, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. shekharm@kci.wayne.edu
We have used the MCF10AT xenograft model of human proliferative breast disease to examine the early effects of estradiol exposure on morphological progression of preneoplastic lesions and to define the step(s) in the morphological sequence at which estrogen may act. The effects of estradiol on neoplastic progression of estrogen-receptor- positive MCF10AT cells in the orthotopic site were examined in ovariectomized female nude mice that received subcutaneous administration of implants of 17beta-estradiol or placebo pellets. At 10 weeks, histological analysis of the lesions derived from the estrogen-supplemented group revealed that 92% of lesions displayed histological features of atypical hyperplasia, carcinoma in situ, or invasive carcinoma, and the remaining 8% exhibited histological features of moderate hyperplasia. These highly proliferative lesions are in marked contrast to the control group in which 60% of samples displayed no evidence of hyperplasia. In contrast with control xenografts, estrogen-exposed xenografts demonstrated extensive areas of papillary growth, adenosis-like areas, prominent host inflammatory infiltration, and angiogenesis. Our results suggest that estrogen exerts a growth-promoting effect on benign or premalignant ductal epithelium by enhancing 1) the frequency of lesion formation, 2) the size of lesions, 3) the speed of transformation from normal/mild hyperplasia to those with atypia, 4) the degree of dysplasia, and 5) angiogenesis.
This article has been cited by other articles:
 |
|
 |
|
  M. P.V. Shekhar, S. Santner, K. A. Carolin, and L. Tait Direct Involvement of Breast Tumor Fibroblasts in the Modulation of Tamoxifen Sensitivity Am. J. Pathol., May 1, 2007; 170(5): 1546 - 1560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P.V. Shekhar, P. Nangia-Makker, L. Tait, F. Miller, and A. Raz Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer Progression: Functional Analysis of Galectin-3 in Breast Epithelial-Endothelial Interactions Am. J. Pathol., December 1, 2004; 165(6): 1931 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. V. Shekhar, A. Lyakhovich, D. W. Visscher, H. Heng, and N. Kondrat Rad6 Overexpression Induces Multinucleation, Centrosome Amplification, Abnormal Mitosis, Aneuploidy, and Transformation Cancer Res., April 1, 2002; 62(7): 2115 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. V. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait Breast Stroma Plays a Dominant Regulatory Role in Breast Epithelial Growth and Differentiation: Implications for Tumor Development and Progression Cancer Res., February 1, 2001; 61(4): 1320 - 1326. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Coradini, M. G. Daidone, P. Boracchi, E. Biganzoli, S. Oriana, G. Bresciani, C. Pellizzaro, G. Tomasic, G. Di Fronzo, and E. Marubini Time-Dependent Relevance of Steroid Receptors in Breast Cancer J. Clin. Oncol., July 14, 2000; 18(14): 2702 - 2709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. V. Shekhar, J. Werdell, and L. Tait Interaction with Endothelial Cells Is a Prerequisite for Branching Ductal-Alveolar Morphogenesis and Hyperplasia of Preneoplastic Human Breast Epithelial Cells: Regulation by Estrogen Cancer Res., January 1, 2000; 60(2): 439 - 449. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
